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Variation in perioperative care across centers for infants undergoing
the Norwood procedure
Sara K. Pasquali, MD, MHS,a Richard G. Ohye, MD,b Minmin Lu, MS,c Jonathan Kaltman, MD,d
Christopher A. Caldarone, MD,e Christian Pizarro, MD,f Carolyn Dunbar-Masterson, BSN, RN,g
J. William Gaynor, MD,h Jeffrey P. Jacobs, MD,i Aditya K. Kaza, MD,j Jane Newburger, MD, MPH,g
John F. Rhodes, MD,a Mark Scheurer, MD,k Eric Silver, MD,l Lynn A. Sleeper, ScD,c
Sarah Tabbutt, MD, PhD,m James Tweddell, MD,n Karen Uzark, PhD,o Winfield Wells, MD,p
William T. Mahle, MD,q and Gail D. Pearson, MD, ScD,d for the Pediatric Heart Network Investigators
Objectives: In the Single Ventricle Reconstruction trial, infants undergoing the Norwood procedure were randomly allocated to undergo a right ventricle-to-pulmonary artery shunt or a modified Blalock-Taussig shunt.
Apart from shunt type, subjects received the local standard of care. We evaluated variation in perioperative
care during the Norwood hospitalization across 14 trial sites.

CHD

Methods: Data on preoperative, operative, and postoperative variables for 546 enrolled subjects who underwent the
Norwood procedure were collected prospectively on standardized case report forms, and variation across the centers
was described.
Results: Gestational age, birth weight, and proportion with hypoplastic left heart syndrome were similar across
sites. In contrast, all recorded variables related to preoperative care varied across centers, including fetal diagnosis
(range, 55%-85%), preoperative intubation (range, 29%-91%), and enteral feeding. Perioperative and operative
factors were also variable across sites, including median total support time (range, 74-189 minutes) and other perfusion variables, arch reconstruction technique, intraoperative medication use, and use of modified ultrafiltration
(range, 48%-100%). Additional variation across centers was seen in variables related to postoperative care, including proportion with an open sternum (range, 35%-100%), median intensive care unit stay (range, 9-44 days),
type of feeding at discharge, and enrollment in a home monitoring program (range, 1%-100%; 5 sites did not
have a program). Overall, in-hospital death or transplant occurred in 18% (range across sites, 7%-39%).
Conclusions: Perioperative care during the Norwood hospitalization varies across centers. Further analysis evaluating the underlying causes and relationship of this variation to outcome is needed to inform future studies and
quality improvement efforts. (J Thorac Cardiovasc Surg 2012;144:915-21)
The Norwood procedure for infants with hypoplastic left
heart syndrome was first described in 1981.1 During the
past 3 decades, outcomes after the Norwood procedure
have improved as a result of refinements in surgical and
perioperative care.2,3 Morbidity and mortality remain

significant, however, and evidence to guide optimal care
is still evolving.4,5
The Pediatric Heart Network, funded by the National
Heart, Lung, and Blood Institute, recently conducted the
Single Ventricle Reconstruction (SVR) trial, in which 555
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Abbreviations and Acronyms
DHCA ¼ deep hypothermic cardiac arrest
ICU ¼ intensive care unit
IQR ¼ interquartile range
RCP ¼ regional cerebral perfusion
SVR ¼ Single Ventricle Reconstruction [trial]

CHD

infants undergoing the Norwood procedure for hypoplastic
left heart syndrome or related single right ventricle anomalies were randomly allocated to receive the right ventricleto-pulmonary artery shunt or modified Blalock-Taussig
shunt as the source of pulmonary blood flow.5 The primary
end point, transplant-free survival 12 months after
randomization, was significantly higher in the right ventricle-to-pulmonary artery shunt group than in the modified
Blalock-Taussig shunt group (74% vs 64%; P ¼ .01).5
Follow-up of the trial cohort continues, to evaluate whether
this survival benefit is maintained.5
Apart from shunt type, subjects enrolled in the SVR trial
received local standard of care, and detailed preoperative, operative, and postoperative information was prospectively collected. Evaluation of these data provides a unique opportunity
to describe the range of care across centers and to assess variation in a large, well-characterized cohort. This is an important first step in identification of areas of potential future
research focus and quality improvement. Previous studies
have suggested variation in several aspects of care for patients
undergoing the Norwood procedure, but they have been
limited in scope and by the use of retrospective survey methodology.4,6,7 The purposes of this analysis were to describe
the range of perioperative care during the Norwood
hospitalization across sites participating in the SVR trial
and to quantitate the degree of interinstitutional variation.
MATERIALS AND METHODS
Patient Population and Trial Design
Details of the SVR trial design (ClinicalTrials.gov number
NCT00115934) have been published previously.8 In brief, infants with
a diagnosis of single, morphological right ventricle undergoing the Norwood procedure were eligible for inclusion in the trial. Exclusion criteria
included single morphological left ventricle, preoperative anatomic features rendering either a modified Blalock-Taussig shunt or a right ventricle-to-pulmonary artery shunt technically impossible, and any major
congenital or acquired extracardiac abnormality thought to independently
affect survival or need for cardiac transplantation. Patients were randomized during 2005 through 2008 at 15 North American clinical centers
with 39 surgeons participating. Dynamic allocation within surgeon was
used to ensure that no single surgeon had a preponderance of either shunt
type. All of the sites were medium- or high-volume congenital heart surgery sites. For the purposes of this analysis, a site that enrolled only 3 patients during the trial was excluded. In the remaining 14 sites, the number of
patients enrolled per site ranged from 10 to 101 (median, 34). The SVR
trial was approved by the institutional review boards at all participating institutions, and informed consent was obtained from a parent or guardian for
each subject.
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Detailed information regarding preoperative, perioperative, operative,
and postoperative care was prospectively recorded on standardized case report forms.8 Apart from the shunt type assigned in the trial, subjects received standard care at their institutions. The postoperative period was
defined as ending at the Norwood hospitalization discharge, or at the stage
II procedure if the patient was not discharged between the operations. The
goal of our study was to describe the range of care across sites in a large,
well-characterized cohort, rather than to determine the specific underlying
causes of any variation identified, so all data related to perioperative care
were included. Some of the variables examined likely primarily reflect
management practices, whereas others may be related more to patient characteristics or outcome. Several variables may represent a combination of
these factors.
Preoperative variables collected included fetal diagnosis, fetal intervention, endotracheal intubation, use of inhaled gases, and enteral feeding.
Perioperative and operative variables included age at surgery, total support
time and perfusion techniques, type of aortic arch reconstruction (classic
method with an allograft or xenograft patch to create the neoaorta vs direct
anastomosis of the pulmonary artery to the arch), use of standard or modified ultrafiltration, and the use of various medications in the operating
room (aprotinin, corticosteroids, and a-blockade with phenoxybenzamine
or phentolamine). Perfusion type was defined as either deep hypothermic
cardiac arrest (DHCA), regional cerebral perfusion (RCP), or a combination of the techniques. Periods as long as 10 minutes of DHCA were included in the RCP group to allow for cannula repositioning. Lowest
temperature during bypass was recorded from a core measurement site (nasopharynx, rectum, or bladder). The lowest hematocrit was recorded during
bypass before initiation of DHCA or RCP.
Postoperative variables included duration of ventilation and hospital
stay, whether the patient had an open sternum, postoperative interventions,
including interventional cardiac catheterization, cardiac surgery, and extracorporeal membrane oxygenation (initiated either in the operating room or
later in the postoperative period), in-hospital death or transplant, type and
route of feeding at discharge, discharge medications, discharge on oxygen,
and enrollment in a home monitoring program (including monitoring of
weight gain, oxygen saturation, or both).

Analysis
Study variables were described with standard summary statistics. Aggregate rates for dichotomous variables and mean  SD, median, and interquartile range (IQR) for continuous variables were calculated for the
overall study population. Next, the total number of centers that used a particular practice or type of care was calculated. For these centers, centerlevel descriptive data were calculated. For continuous variables, the median
value at each site was calculated; for dichotomous variables, the proportion
of cases at each center in which the practice or type of care was used was
calculated. Median, IQR, and range were then calculated from these centerlevel data. Because of the descriptive nature of the analysis, formal statistical comparisons were not made. All analyses were performed with the
SAS version 9.2 statistical software package (SAS Institute, Inc, Cary, NC).

RESULTS
Study Population
Of 555 patients enrolled in the SVR trial, 5 patients had
consent given but did not undergo the Norwood procedure,
and 1 patient was withdrawn immediately after the Norwood
procedure was performed such that no further follow-up information was collected. In addition, a site that enrolled only
3 patients was excluded. Thus the 546 remaining patients
from 14 trial sites are the basis for analysis. Median birth
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Preoperative Variables
Preoperative variables are displayed in Table 1. Most patients (76%) had their condition diagnosed in utero; however, this varied across centers, ranging from 55% to
85%. Approximately half of patients were intubated preoperatively, with a range of 29% to 91% of patients across
centers. Five percent overall were specifically intubated
for transport (range, 1%-15% across 11 sites).
A minority of patients received all other preoperative
therapies and interventions noted in Table 1, including fetal
intervention, use of inhaled gases, and enteral feeding. Although used in a minority of patients overall, these factors
also varied across sites, with the greatest variation seen in
enteral feeding.
Perioperative and Operative Variables
Perioperative and operative variables are displayed in
Table 2. The median age at surgery ranged from 4 to 7
days across sites. Among those who were preterm (<37
weeks’ gestation; n ¼ 64), median age at surgery ranged
from 2 to 23 days across centers. Total support and crossclamp times varied more than 2-fold. There was also variation in the use of DHCA and RCP across sites, along with the
lowest core temperature on bypass and lowest hematocrit
(Table 2). Arch reconstruction was accomplished by the
classic method in most cases. Direct anastomosis of the pulmonary artery to the arch was used in a minority of patients
at 9 sites and in the majority of patients at 1 site. Ultrafiltration of any type was used at all sites; at 13 sites, it was used in
most cases. Modified ultrafiltration was used at 10 sites.
Perioperative steroids were used at all sites; they were administered to 100% of patients at 7 sites and to most patients
at all but 1 site. Aprotinin was also used at all sites (while
still available) and was used in most cases at all but 1 site.
There was more variability in the use of a-blockade, with

6 sites not using it at all and the remaining sites using it in
2% to 100% of cases.
Postoperative Variables
Postoperative variables are displayed in in Table 3. There
was a 4-fold difference in duration of ventilation across sites
and a nearly 5-fold variation in intensive care unit (ICU)
stay. Twenty-two patients (4%) overall were kept in the
hospital until their stage II surgery, with a range of 1% to
22% of patients across 8 sites. More than three-quarters
of patients had an open sternum after the Norwood operation; this also varied across sites, ranging from 35% to
100%. At 7 sites, all patients had an open sternum. Extracorporeal membrane oxygenation use ranged from 7% to
35% across sites. Interventional cardiac catheterizations
and cardiac surgery in the postoperative period before discharge were infrequent but variable by site, ranging from
6% to 20% and 3% to 40%, respectively. Five centers
did not perform any interventional catheterizations, and 3
centers did not perform any cardiac surgeries in the postoperative period after the Norwood procedure. Overall, 18%
of patients died or underwent transplant during the primary
hospitalization, with a range of 7% to 39% across sites
(Table 3).
All surviving patients were discharged with at least 1
medication. The most frequent discharge medications included aspirin (87%), furosemide (85%), ranitidine
(50%), metoclopramide (38%), and digoxin (36%). The
type and route of feeding were highly variable across sites.
Only a third of patients overall were feeding by mouth without any nasogastric or gastric feeds at discharge, and fewer
than half were receiving breast milk (alone or in combination with formula). A minority of patients (11%) were discharged home with supplemental oxygen, but this varied by
site from 2% to 57%. A third of discharged patients were
enrolled in a home monitoring program; 5 sites did not
have such a program.
DISCUSSION
This analysis describes the wide range of perioperative
care across clinical centers for patients undergoing the

TABLE 1. Variation in preoperative variables
Center-level data
Variable

Aggregate rate

No. of centers

Median

Interquartile range

Range

Fetal diagnosis
Fetal intervention*
Intubation
Inhaled gases
Carbon dioxide
Nitrogen
Enteral feeding

76%
3%
48%

14
5
14

73%
3%
50%

71%-82%
2%-4%
38%-64%

55%-85%
1%-17%
29%-91%

3%
13%
12%

5
9
13

16%
15%
11%

1%-20%
9%-36%
4%-22%

1%-40%
1%-55%
1%-100%

Number of centers refers to the number out of the 14 total centers that used a particular practice or type of care. Subsequent center-level descriptive data in the table refer to only
these centers. *Includes both patients who underwent fetal intervention at their center and those referred to another institution to undergo fetal intervention.
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weight was 3.1 kg (IQR, 2.8-3.5 kg), median gestational age
was 38 weeks (IQR, 37-39 weeks), and 86% had a diagnosis
of hypoplastic left heart syndrome (vs other single right ventricle defects). Of note, there were no significant differences
in any of these variables across sites.

Congenital Heart Disease

Pasquali et al

TABLE 2. Variation in operative and perioperative variables
Aggregate data

CHD

Variable

Rate

Mean ± SD

Age at Norwood (d)
Perfusion data
Total support time (min)
Crossclamp time (min)
DHCA only
DHCA time (min)
RCP only
RCP time (min)
RCP flow
(mL/kg/min)
Both DHCA and RCP
DHCA time (min)
RCP time (min)
RCP flow
(mL/kg/min)
Lowest temperature ( C)
Lowest hematocrit (%)
Arch reconstruction
Classic
Direct PA to arch
Ultrafiltration
Any
Modified
Medications
Aprotinin
Corticosteroids
a-Blockade

—

5.8  4.1

—
—
54%
—
24%
—
—

144  54
56  23
—
47  18
—
57  17
42  17

22%
—
—
—

Center-level data

Median (IQR)

No. of centers

Median

IQR

Range

14

5

4-6

4-7

139 (105-171)
53 (40-67)
—
42 (36-54)
—
55 (46-66)
38 (30-50)

14
14
9
9
10
10
10

149
57
97%
51
38%
52
36

124-166
48-64
22%-100%
46-55
19%-82%
45%-59
30-49

74-189
33-73
3%-100%
33-73
3%-93%
30%-76
19-50

—
25  16
46  22
37  16

—
21 (13-34)
50 (26-61)
35 (25-49)

9
9
9
9

42%
24
48
30

18%-60%
15-34
37-60
30-40

4%-87%
12-71
23-71
19-54

—
—

17  2
30  5

17 (16-18)
29 (27-32)

14
14

17
29

17-18
28-31

15-21
22-41

88%
12%

—
—

—
—

14
9

97%
15%

82%-100%
4%-22%

41%-100%
3%-59%

84%
66%

—
—

—
—

14
10

94%
94%

88%-100%
88%-100%

2%-100%
48%-100%

78%
91%
45%

—
—
—

—
—
—

14
14
8

87%
99%
90%

60%-93%
96%-100%
64%-97%

43%-100%
33%-100%
2%-100%

5 (3-7)

Number of centers refers to the number out of the 14 total centers that used a particular practice or type of care. Subsequent center-level descriptive data in the table refer to only
these centers. DHCA, Deep hypothermic circulatory arrest; IQR, interquartile range; PA, pulmonary artery; RCP, regional cerebral perfusion; SD, standard deviation.

Norwood procedure. Virtually every aspect of preoperative,
operative, and postoperative care evaluated in this analysis
varied across 14 sites participating in the SVR trial. Variation can foster scientific discovery and innovation and allow
treatment plans to be individually tailored to the patient.
Nevertheless, the degree of variability demonstrated in
our analysis and others may also highlight the limited evidence to guide optimal care in this population and the
lack of best practice guidelines.9 This in turn may play
a role in the wide variability in outcomes after the Norwood
operation. A recent analysis of more than 2000 infants undergoing the Norwood operation across 69 centers showed
that adjusted in-hospital mortality varied by 6-fold from
7% to 42% across centers.10 Data from our study, although
from a smaller subset of hospitals, are similar, with the rate
of in-hospital death or transplant varying from 7% to 39%
across institutions. It has also been shown that variation in
practice can account for a significant proportion of health
care expenditures, which is of particular importance in
this era of rising health care costs.11
This analysis builds on previous surveys of differences in
practice across centers for patients undergoing the Norwood
918

operation. In 2007, Wernovsky and colleagues6 surveyed 52
international centers performing the Norwood operation
and reported wide variation in ICU models of care, operative and perfusion techniques, medications, feeding regimens, and postoperative monitoring.6 Other surveys
evaluating not only patients undergoing Norwood operations but others undergoing congenital heart surgery have
found wide variation in perfusion techniques and postoperative care models, including ICU structure and personnel.4,12 More recent studies have also analyzed specific
practices in the Norwood population. Johnson and
associates7 evaluated 1283 infants undergoing the Norwood
procedure from 45 centers in the Society of Thoracic Surgeons Congenital Heart Surgery Database and showed
that use of delayed sternal closure varied widely across centers. Other studies have evaluated a wider range of practices
in patients undergoing the Norwood operation but have
been limited by analyzing only survivors to hospital discharge.13,14 This study builds on these previous analyses
through using prospectively collected data related to
perioperative care, as opposed to retrospective survey
methodology, and evaluating a wide range of care
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TABLE 3. Variation in postoperative variables
Center-level data

Variable

Rate

Mean ± SD

Median (IQR)

No. of centers

Median

IQR

Range

Total ICU stay (d)
Total hospital stay (d)
Ratio of ICU to total stay
Ventilator time (d)
Extubation within 72 h (%)
Open sternum (%)
ECMO (%)
Interventional catheterization (%)
Cardiac surgery (%)
Feeding at discharge
Oral only (%)
Any oral (%)
Any G/GJ tube (%)
Any NG/NJ tube (%)
Breast milk (any route, %)
No. of discharge medications
Discharge with oxygen support
Home monitoring program
Death or transplant during Norwood
hospitalization (%)

—
—
—
—
18%
78%
16%
7%
8%

24  31
35  34
0.7  0.3
12  25
—
—
—
—
—

14 (9-25)
24 (17-40)
0.6 (0.5-1.0)
7 (5-11)
—
—
—
—
—

14
14
14
14
6
14
13
9
11

13
25
0.6
7
24%
99%
18%
8%
8%

12-18
22-32
0.5-0.6
6-9
6%-32%
67%-100%
13%-20%
6%-11%
4%-13%

9-44
19-44
0.5-1.0
4-16
5%-63%
35%-100%
7%-35%
6%-20%
3%-40%

33%
78%
18%
49%
48%
—
11%
33%
18%

—
—
—
—
—
52
—
—
—

12
14
12
11
14
14
11
9
14

29%
79%
20%
60%
47%
5
11%
69%
17%

18%-44%
56%-90%
13%-27%
53%-78%
39%-57%
4-6
5%-24%
50%-96%
15%-30%

3%-81%
33%-100%
2%-72%
8%-100%
17%-67%
3-6
2%-57%
1%-100%
7%-39%

—
—
—
—
—
5 (4-6)
—
—
—

Number of centers refers to the number out of the 14 total centers that used a particular practice or type of care. Subsequent center-level descriptive data in the table refer to only
these centers. Data on length of stay and duration of ventilation, along with discharge data, exclude those who did not survive to hospital discharge or underwent cardiac transplant
during the same admission (n ¼ 97). IQR, Interquartile range; SD, standard deviation; ECMO, extracorporeal membrane oxygenation; G, gastric; GJ, gastrojejunal; ICU, intensive
care unit; NG, nasogastric; NJ, nasojejunal.

encompassing the entire Norwood hospitalization for all
patients enrolled in the SVR trial.
In the field of adult cardiac surgery, it has been shown that
evaluation of variation in care across centers is a critical first
step toward identifying areas of future research, development of quality improvement initiatives, and subsequent
implementation of best practice guidelines. Prager and colleagues15 recently reported on The Michigan Society of
Thoracic and Cardiovascular Surgeons quality collaborative. This group, composed of all adult cardiac surgery programs in Michigan, meets regularly to evaluate variation in
practice and program outcomes. Through the adoption of
practices used by high-performing sites, variation in care
is reduced, outcomes are improved, and hospital costs are
lowered. For example, after sharing of protocols to facilitate
timely extubation, variation in duration of ventilation across
sites was reduced, and the overall rate of prolonged ventilation decreased from 19% to 14%.15 The Northern New England Cardiovascular Disease Study Group pioneered work
in this area in adult cardiac surgery in the 1980s, and their
experience has also shown that a precise assessment of variation in practice and outcomes across institutions is a critical first step.16 In pediatric cardiology, the Joint Council on
Congenital Heart Disease National Pediatric Cardiology
Quality Improvement Collaborative has recently begun
evaluating practice variation across sites with regard to
feeding and home monitoring practices in the interstage

period between the Norwood and stage II procedures.17
These analyses are ongoing. Efforts are currently underway
to develop a quality improvement collaborative in pediatric
heart surgery.
Few previous studies have evaluated the impact on outcome of variation in management during the Norwood hospitalization. In their analysis of variation in the use of
delayed sternal closure after the Norwood procedure, Johnson and associates7 found that centers with greater use of delayed sternal closure had significantly higher rates of
postoperative infection and prolonged stay, differences
that persisted after accounting for a variety of patient and
center factors. Variation in the use of perioperative corticosteroids and its impact on outcome have also been previously evaluated. In a large study of more than 45,000
patients from 38 centers, perioperative corticosteroid use
was found to vary widely by center, and in subgroup analysis, there was no significant benefit associated with corticosteroids in the high-risk group primarily composed of
patients undergoing the Norwood procedure.18 Finally, investigators have also evaluated variation in center-related
variables and impact on outcome. Analyses of both clinical
and administrative datasets have found variation in ICU
models of care (dedicated cardiac ICU vs general pediatric
ICU) but have shown no significant impact of ICU type on
outcome in patients undergoing the Norwood operation.19,20
Further evaluation of these and other variables examined in
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this study will help to determine which aspects of variation
in care are reflective of local practices or underlying patient
characteristics and are not independently associated with
outcome and which are associated with improved
outcomes and should be evaluated as best practices.
Rather than through a single study or trial, this may best
be accomplished through a collaborative effort focused on
sharing of information across sites and continuous quality
improvement to identify best practices, reduce variation in
care, and improve outcomes, similar to initiatives in adult
cardiac surgery.15,16

CHD

Limitations
There are several limitations to this analysis. This study
focused on a subset of medium- and high-volume centers
performing the Norwood procedure, and only patients enrolled in the SVR trial were included. We thus may have actually underestimated the degree of variation in care across
all patients and across all sites performing this operation. In
this initial analysis, we focused on describing the range of
care across centers in a large cohort and did not evaluate
the potential role of variation in care within centers, random
variation between centers, or change over time. These factors will require further study. We were inherently limited
to evaluating aspects of perioperative care recorded in the
SVR trial data set. There may be other patient and centerlevel variables that are relevant. As noted previously, the
relationship of the variation identified in this study with outcome will also require further study. Finally, in this analysis
we have not separated out variation in care specifically related to practice or management from the patient’s severity
of disease, although we did find that the baseline patient
characteristics we examined did not differ across sites. It
is likely that for several of the variables we evaluated,
many factors may play a role and require further analysis.
CONCLUSIONS
We have described the wide range of perioperative care
across clinical centers performing the Norwood procedure.
Further analysis is necessary to evaluate the underlying causes
of this variation and relationship of variation in management
to patient outcomes, including survival, neurodevelopmental
outcomes, and cost. These analyses may aid in planning future
clinical trials, allow us to begin to identify best practices, and
facilitate the development of quality improvement initiatives
to improve quality of care and outcomes across centers for
patients undergoing the Norwood procedure.
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